BICYCLE THERAPEUTICS

• 82990 - Other business support service activities n.e.c.

Our aim is to become one of the world's leading solid tumor medicines companies, initially measured by our pipeline's potential, and ultimately by the number of patients we are able to treat... Outside of oncology, we hope to fully explore the potential of using Bicycles to tackle a variety of hard-to-drug targets in areas of high unmet medical need. We are collaborating with a wide range of pharma partners, leading academics, and public bodies to explore how we might develop innovative new medicines in respiratory, cardiovascular and metabolic disease, ophthalmology, anti-infective, dementia, central nervous system and neuromuscular therapy areas. These partnerships could enhance our future ability to bring this important class of medicines to patients with debilitating diseases, without distracting from our core mission to deliver new drugs for oncology... To achieve a therapeutic effect while minimizing undesired side-effects in patients, drugs must bind to target proteins with..

Also known as: Bicycle Therapeutics Group, BICYCLE THERAPEUTICS PLC, Bicycle Therapeutics, Inc.

Registration numbers: 11036004 (CH)

Primary location: Cambridge United States